Antoine Italiano

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Antoine Italiano
Mar 25, 2025, 06:44 | Blog
Javier Martin-Broto: Immunotherapy in combination in ESMO Sarcoma and Rare Cancers 2025
Javier Martin-Broto, Sarcoma Medical Oncologist at the Jiménez Díaz Foundation University Hospital, shared a post…
Jan 14, 2025, 16:44 | Blog
Tertiary lymphoid structures and cancer immunotherapy
Aleix Prat shared on LinkedIn: "Tertiary lymphoid structures (TLSs) are increasingly recognized as key players in…
Jan 8, 2025, 11:37 | Blog
Aakash Desai: Sacituzumab govitecan continues to show promise as a 2-line treatment for extensive-stage SCLC
Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "Sacituzumab govitecan…
Dec 25, 2024, 12:40 | Opinion
5 Articles suggested by Wafik El-Deiry
 Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at…
Oct 18, 2024, 15:29 | Insight
Vivek Subbiah: The power of Tissue-Agnostic in Precision Medicine
Vivek Subbiah shared a post by Antonio Calles, Head, Lung Cancer Unit at Hospital Ruber Internacional, on…
Sep 15, 2024, 02:08 | Blog
Sahar Barjesteh van Waalwijk: How can we make such medicines available through insurance coverage?
Sahar Barjesteh van Waalwijk, Pharmacist and Member of National Funder's Committee for Evaluation of Specialised Medicine…
Sep 14, 2024, 00:00 | Insight
Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer
Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…
Sep 7, 2024, 09:28 | Drugs
Elvina Almuradova: Doxorubicin with Trabectedin show promising results for patients with leiomyosarcoma
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on LinkedIn: "New findings published…
Sep 6, 2024, 13:28 | Insight
Biagio Ricciuti: How adaptive mechanisms and increased GTP loading confer resistance to KRAS G12C OFF
Biagio Ricciuti shared on X: “Our in Nature Communications our collaborative effort showing how adaptive mechanisms…
Aug 13, 2024, 14:52 | Insight
5 articles suggested by Yüksel Ürün
Yüksel Ürün shared a few must-reads paper on X: 1. Molecularly guided therapy versus chemotherapy…
May 28, 2024, 14:22 | Insight
Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer - UCLA Health
Combining immune-targeted therapy with chemotherapy improves both progression-free survival and overall survival when compared to…
All: 11 Posts: 1 - 100
Special Coverage